> top > docs > PubMed:32846167 > annotations

PubMed:32846167 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 17-23 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T2 114-120 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T3 496-501 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T4 688-693 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T5 763-781 Body_part denotes glycosaminoglycans http://purl.org/sig/ont/fma/fma63011
T6 783-787 Body_part denotes GAGs http://purl.org/sig/ont/fma/fma63011
T7 801-816 Body_part denotes heparan sulfate http://purl.org/sig/ont/fma/fma63023
T8 818-820 Body_part denotes HS http://purl.org/sig/ont/fma/fma63023
T9 903-905 Body_part denotes HS http://purl.org/sig/ont/fma/fma63023
T10 909-913 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T11 948-954 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T12 1010-1013 Body_part denotes GAG http://purl.org/sig/ont/fma/fma63011
T13 1033-1035 Body_part denotes HS http://purl.org/sig/ont/fma/fma63023
T14 1076-1080 Body_part denotes GAGs http://purl.org/sig/ont/fma/fma63011
T15 1084-1090 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T16 1197-1201 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T17 1319-1325 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T18 1401-1407 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T19 1823-1829 Body_part denotes xylose http://purl.org/sig/ont/fma/fma82804
T20 1859-1874 Body_part denotes glucuronic acid http://purl.org/sig/ont/fma/fma82798
T21 1876-1895 Body_part denotes N-acetylglucosamine http://purl.org/sig/ont/fma/fma82787
T22 1899-1918 Body_part denotes N-acetylglucosamine http://purl.org/sig/ont/fma/fma82787
T23 1920-1941 Body_part denotes N-acetylgalactosamine http://purl.org/sig/ont/fma/fma82786
T24 1943-1952 Body_part denotes galactose http://purl.org/sig/ont/fma/fma82794

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 909-913 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T2 1197-1201 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 71-79 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 141-149 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 155-159 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T4 393-408 Disease denotes Type 2 diabetes http://purl.obolibrary.org/obo/MONDO_0005148
T5 400-408 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T6 427-447 Disease denotes respiratory diseases http://purl.obolibrary.org/obo/MONDO_0005087
T7 449-456 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122
T8 462-474 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T9 476-488 Disease denotes Inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T10 578-597 Disease denotes respiratory disease http://purl.obolibrary.org/obo/MONDO_0005087
T11 626-634 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 668-680 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T13 709-724 Disease denotes Type 2 diabetes http://purl.obolibrary.org/obo/MONDO_0005148
T14 716-724 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T15 914-924 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T16 929-944 Disease denotes Type 2 diabetes http://purl.obolibrary.org/obo/MONDO_0005148
T17 936-944 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T18 1202-1212 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T19 1293-1301 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 1494-1502 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 1578-1586 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 1614-1620 Disease denotes scurvy http://purl.obolibrary.org/obo/MONDO_0009412
T23 1675-1682 Disease denotes obesity http://purl.obolibrary.org/obo/MONDO_0011122

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 215-218 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T2 496-501 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T3 688-693 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T4 909-913 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T5 909-913 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T6 1038-1041 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T7 1197-1201 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T8 1197-1201 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T9 1354-1355 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 1588-1589 http://purl.obolibrary.org/obo/CLO_0001020 denotes A

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T23 1002-1009 Chemical denotes sulfate http://purl.obolibrary.org/obo/CHEBI_16189
T1 15-23 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T4 17-23 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T5 112-120 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T8 114-120 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T9 125-136 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T10 763-781 Chemical denotes glycosaminoglycans http://purl.obolibrary.org/obo/CHEBI_18085
T11 783-787 Chemical denotes GAGs http://purl.obolibrary.org/obo/CHEBI_18085
T12 801-816 Chemical denotes heparan sulfate http://purl.obolibrary.org/obo/CHEBI_28815
T13 801-808 Chemical denotes heparan http://purl.obolibrary.org/obo/CHEBI_24500
T14 809-816 Chemical denotes sulfate http://purl.obolibrary.org/obo/CHEBI_16189
T15 818-820 Chemical denotes HS http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815
T17 903-905 Chemical denotes HS http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815
T19 946-954 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T22 948-954 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T24 1010-1013 Chemical denotes GAG http://purl.obolibrary.org/obo/CHEBI_143889
T25 1033-1035 Chemical denotes HS http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815
T27 1076-1080 Chemical denotes GAGs http://purl.obolibrary.org/obo/CHEBI_18085
T28 1082-1090 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T31 1084-1090 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T32 1095-1102 Chemical denotes xylitol http://purl.obolibrary.org/obo/CHEBI_17151
T33 1154-1163 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T34 1243-1254 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T35 1317-1325 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T38 1319-1325 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T39 1326-1333 Chemical denotes xylitol http://purl.obolibrary.org/obo/CHEBI_17151
T40 1399-1407 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T43 1401-1407 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T44 1412-1423 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T45 1525-1548 Chemical denotes anti-inflammatory drugs http://purl.obolibrary.org/obo/CHEBI_35472
T46 1543-1548 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T47 1821-1829 Chemical denotes D-xylose http://purl.obolibrary.org/obo/CHEBI_15936|http://purl.obolibrary.org/obo/CHEBI_53455|http://purl.obolibrary.org/obo/CHEBI_65327
T50 1823-1829 Chemical denotes xylose http://purl.obolibrary.org/obo/CHEBI_18222
T51 1831-1838 Chemical denotes xylitol http://purl.obolibrary.org/obo/CHEBI_17151
T52 1851-1855 Chemical denotes Acid http://purl.obolibrary.org/obo/CHEBI_37527
T53 1857-1874 Chemical denotes D-glucuronic acid http://purl.obolibrary.org/obo/CHEBI_4178|http://purl.obolibrary.org/obo/CHEBI_47952|http://purl.obolibrary.org/obo/CHEBI_47953
T56 1859-1874 Chemical denotes glucuronic acid http://purl.obolibrary.org/obo/CHEBI_24298
T57 1870-1874 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T58 1876-1895 Chemical denotes N-acetylglucosamine http://purl.obolibrary.org/obo/CHEBI_28009|http://purl.obolibrary.org/obo/CHEBI_59640
T60 1899-1918 Chemical denotes N-acetylglucosamine http://purl.obolibrary.org/obo/CHEBI_28009|http://purl.obolibrary.org/obo/CHEBI_59640
T62 1920-1941 Chemical denotes N-acetylgalactosamine http://purl.obolibrary.org/obo/CHEBI_28800
T63 1943-1952 Chemical denotes galactose http://purl.obolibrary.org/obo/CHEBI_28260

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 393-408 Phenotype denotes Type 2 diabetes http://purl.obolibrary.org/obo/HP_0005978
T2 449-456 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513
T3 462-474 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T4 532-552 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T5 709-724 Phenotype denotes Type 2 diabetes http://purl.obolibrary.org/obo/HP_0005978
T6 929-944 Phenotype denotes Type 2 diabetes http://purl.obolibrary.org/obo/HP_0005978
T7 1675-1682 Phenotype denotes obesity http://purl.obolibrary.org/obo/HP_0001513

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 476-488 http://purl.obolibrary.org/obo/GO_0006954 denotes Inflammation
T2 668-680 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T3 748-759 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T4 888-899 http://purl.obolibrary.org/obo/GO_0009056 denotes degradation
T5 1048-1060 http://purl.obolibrary.org/obo/GO_0031099 denotes regeneration

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-150 Sentence denotes Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
T2 151-475 Sentence denotes The SARS-Cov-2 pandemic that currently affects the entire world has been shown to be especially dangerous in the elderly (≥65 years) and in smokers, with notably strong comorbidity in patients already suffering from chronic diseases, such as Type 2 diabetes, cancers, chronic respiratory diseases, obesity, and hypertension.
T3 476-635 Sentence denotes Inflammation of the lungs is the main factor leading to respiratory distress in patients with chronic respiratory disease and in patients with severe COVID-19.
T4 636-822 Sentence denotes Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS).
T5 823-945 Sentence denotes Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes.
T6 946-1081 Sentence denotes D-xylose, which is the initiating element for different sulfate GAG chains (especially HS), has shown regeneration properties for GAGs.
T7 1082-1255 Sentence denotes D-xylose and xylitol have demonstrated anti-inflammatory, antiglycemic, antiviral, and antibacterial properties in lung infections, alone or in combination with antibiotics.
T8 1256-1587 Sentence denotes Considering the existing research on COVID-19 and related to D-xylose/xylitol, this review offers a perspective on why the association between D-xylose and antibiotics may contribute to significantly reducing the duration of treatment of COVID-19 patients and why some anti-inflammatory drugs may increase the severity of COVID-19.
T9 1588-1708 Sentence denotes A strong correlation with scurvy, based on gender, age, ethnicity, smoking status, and obesity status, is also reviewed.
T10 1709-1800 Sentence denotes Related to this, the effects of treatment with plants such as Artemisia are also addressed.
T11 1801-1953 Sentence denotes CHEMICAL COMPOUNDS: D-xylose; xylitol; l-ascorbic Acid; D-glucuronic acid; N-acetylglucosamine; D-N-acetylglucosamine; N-acetylgalactosamine; galactose.
T1 0-150 Sentence denotes Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
T2 151-475 Sentence denotes The SARS-Cov-2 pandemic that currently affects the entire world has been shown to be especially dangerous in the elderly (≥65 years) and in smokers, with notably strong comorbidity in patients already suffering from chronic diseases, such as Type 2 diabetes, cancers, chronic respiratory diseases, obesity, and hypertension.
T3 476-635 Sentence denotes Inflammation of the lungs is the main factor leading to respiratory distress in patients with chronic respiratory disease and in patients with severe COVID-19.
T4 636-822 Sentence denotes Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS).
T5 823-945 Sentence denotes Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes.
T6 946-1081 Sentence denotes D-xylose, which is the initiating element for different sulfate GAG chains (especially HS), has shown regeneration properties for GAGs.
T7 1082-1255 Sentence denotes D-xylose and xylitol have demonstrated anti-inflammatory, antiglycemic, antiviral, and antibacterial properties in lung infections, alone or in combination with antibiotics.
T8 1256-1587 Sentence denotes Considering the existing research on COVID-19 and related to D-xylose/xylitol, this review offers a perspective on why the association between D-xylose and antibiotics may contribute to significantly reducing the duration of treatment of COVID-19 patients and why some anti-inflammatory drugs may increase the severity of COVID-19.
T9 1588-1708 Sentence denotes A strong correlation with scurvy, based on gender, age, ethnicity, smoking status, and obesity status, is also reviewed.
T10 1709-1800 Sentence denotes Related to this, the effects of treatment with plants such as Artemisia are also addressed.
T11 1801-1953 Sentence denotes CHEMICAL COMPOUNDS: D-xylose; xylitol; l-ascorbic Acid; D-glucuronic acid; N-acetylglucosamine; D-N-acetylglucosamine; N-acetylgalactosamine; galactose.

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-150 Sentence denotes Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
T2 151-475 Sentence denotes The SARS-Cov-2 pandemic that currently affects the entire world has been shown to be especially dangerous in the elderly (≥65 years) and in smokers, with notably strong comorbidity in patients already suffering from chronic diseases, such as Type 2 diabetes, cancers, chronic respiratory diseases, obesity, and hypertension.
T3 476-635 Sentence denotes Inflammation of the lungs is the main factor leading to respiratory distress in patients with chronic respiratory disease and in patients with severe COVID-19.
T4 636-822 Sentence denotes Several studies have shown that inflammation of the lungs in general and Type 2 diabetes are accompanied by the degradation of glycosaminoglycans (GAGs), especially heparan sulfate (HS).
T5 823-945 Sentence denotes Several studies have also shown the importance of countering the degradation of HS in lung infections and Type 2 diabetes.
T6 946-1081 Sentence denotes D-xylose, which is the initiating element for different sulfate GAG chains (especially HS), has shown regeneration properties for GAGs.
T7 1082-1255 Sentence denotes D-xylose and xylitol have demonstrated anti-inflammatory, antiglycemic, antiviral, and antibacterial properties in lung infections, alone or in combination with antibiotics.
T8 1256-1587 Sentence denotes Considering the existing research on COVID-19 and related to D-xylose/xylitol, this review offers a perspective on why the association between D-xylose and antibiotics may contribute to significantly reducing the duration of treatment of COVID-19 patients and why some anti-inflammatory drugs may increase the severity of COVID-19.
T9 1588-1708 Sentence denotes A strong correlation with scurvy, based on gender, age, ethnicity, smoking status, and obesity status, is also reviewed.
T10 1709-1800 Sentence denotes Related to this, the effects of treatment with plants such as Artemisia are also addressed.
T11 1801-1953 Sentence denotes CHEMICAL COMPOUNDS: D-xylose; xylitol; l-ascorbic Acid; D-glucuronic acid; N-acetylglucosamine; D-N-acetylglucosamine; N-acetylgalactosamine; galactose.

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 801-816 GlycoEpitope denotes heparan sulfate http://www.glycoepitope.jp/epitopes/EP0086
T2 818-820 GlycoEpitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T3 903-905 GlycoEpitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086
T4 1033-1035 GlycoEpitope denotes HS http://www.glycoepitope.jp/epitopes/EP0086

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
4 15-23 Chemical denotes D-xylose MESH:D014994
5 71-79 Disease denotes COVID-19 MESH:C000657245
6 112-120 Chemical denotes D-xylose MESH:D014994
7 141-149 Disease denotes COVID-19 MESH:C000657245
53 155-165 Species denotes SARS-Cov-2 Tax:2697049
54 335-343 Species denotes patients Tax:9606
55 367-383 Disease denotes chronic diseases MESH:D002908
56 393-408 Disease denotes Type 2 diabetes MESH:D003924
57 410-417 Disease denotes cancers MESH:D009369
58 427-447 Disease denotes respiratory diseases MESH:D012140
59 449-456 Disease denotes obesity MESH:D009765
60 462-474 Disease denotes hypertension MESH:D006973
61 476-488 Disease denotes Inflammation MESH:D007249
62 532-552 Disease denotes respiratory distress MESH:D012128
63 556-564 Species denotes patients Tax:9606
64 578-597 Disease denotes respiratory disease MESH:D012140
65 605-613 Species denotes patients Tax:9606
66 626-634 Disease denotes COVID-19 MESH:C000657245
67 668-680 Disease denotes inflammation MESH:D007249
68 716-724 Disease denotes diabetes MESH:D003920
69 763-781 Chemical denotes glycosaminoglycans MESH:D006025
70 783-787 Chemical denotes GAGs MESH:D006025
71 801-816 Chemical denotes heparan sulfate MESH:D006497
72 818-820 Chemical denotes HS MESH:D006497
73 909-924 Disease denotes lung infections MESH:D012141
74 929-944 Disease denotes Type 2 diabetes MESH:D003924
75 946-954 Chemical denotes D-xylose MESH:D014994
76 1010-1013 Chemical denotes GAG MESH:D006025
77 1033-1035 Chemical denotes HS MESH:D006497
78 1076-1080 Chemical denotes GAGs MESH:D006025
79 1082-1090 Chemical denotes D-xylose MESH:D014994
80 1095-1102 Chemical denotes xylitol MESH:D014993
81 1197-1212 Disease denotes lung infections MESH:D012141
82 1293-1301 Disease denotes COVID-19 MESH:C000657245
83 1317-1325 Chemical denotes D-xylose MESH:D014994
84 1326-1333 Chemical denotes xylitol MESH:D014993
85 1399-1407 Chemical denotes D-xylose MESH:D014994
86 1494-1502 Disease denotes COVID-19 MESH:C000657245
87 1503-1511 Species denotes patients Tax:9606
88 1578-1586 Disease denotes COVID-19 MESH:C000657245
89 1675-1689 Disease denotes obesity status MESH:D009765
90 1821-1829 Chemical denotes D-xylose MESH:D014994
91 1831-1838 Chemical denotes xylitol MESH:D014993
92 1840-1855 Chemical denotes l-ascorbic Acid MESH:D001205
93 1857-1874 Chemical denotes D-glucuronic acid MESH:D020723
94 1876-1895 Chemical denotes N-acetylglucosamine MESH:D000117
95 1897-1918 Chemical denotes D-N-acetylglucosamine
96 1920-1941 Chemical denotes N-acetylgalactosamine MESH:D000116
97 1943-1952 Chemical denotes galactose MESH:D005690